Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported Outcomes

Raisa Epistola1 Department of Internal Medicine, Division of Hematology and Medical Oncology, Harbor UCLA Medical Center, Torrance, CA, USACorrespondence[email protected] [email protected]

Rubens Sperandio2 Centro de Oncologia e Hematologia Einstein Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil

Zev Wainberg3 Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA

Syma Iqbal4 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

Joseph Chao5 Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Your download is now in progress and you may close this window